Advertisement
Screener

NIAGEN BIOSCIENCE, INC. (NAGE) Deferred Revenue, Revenue Recognized

2.8 / 5 stars · 68/120 Roast Me

NIAGEN BIOSCIENCE, INC. Deferred Revenue, Revenue Recognized

NIAGEN BIOSCIENCE, INC. (NAGE) reported Deferred Revenue, Revenue Recognized of $432.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-12.

Discontinued › Income Statement › Other Income

us-gaap:DeferredRevenueRevenueRecognized1 · last filed 2021-03-12

  • NIAGEN BIOSCIENCE, INC. deferred revenue, revenue recognized for the quarter ending 2019-09-30 was $0.00.
  • NIAGEN BIOSCIENCE, INC. deferred revenue, revenue recognized for the quarter ending 2019-03-31 was $38.00K.
  • NIAGEN BIOSCIENCE, INC. deferred revenue, revenue recognized for fiscal 2020 was $432.00K, a 240.16% increase from fiscal 2019.
  • NIAGEN BIOSCIENCE, INC. deferred revenue, revenue recognized for fiscal 2019 was $127.00K.
  • NIAGEN BIOSCIENCE, INC. deferred revenue, revenue recognized for fiscal 2018 was $0.00.
Period endDeferred Revenue, Revenue Recognized 3 monthDeferred Revenue, Revenue Recognized 9 monthDeferred Revenue, Revenue Recognized 12 month
2020-12-31$432.00K
10-K · filed 2021-03-12
2019-12-31$127.00K
10-K · filed 2021-03-12
2019-09-30$0.00
10-Q · filed 2019-11-12
$127.00K
10-Q · filed 2019-11-12
2019-03-31$38.00K
10-Q · filed 2019-05-09
2018-12-31$0.00
10-K · filed 2020-03-10

Similar stocks

Stock NameCountryMarket CapPE Ratio
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
Canopy Growth Corp (CGC)$0.395B
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Cronos Group Inc. (CRON)$1.223B
Definium Therapeutics, Inc. (DFTX)United States$4.931B-17.87